Lisa M. Holle
Clinical Professor/Pharmacy Practice
Storrs Mansfield
Are you Lisa M. Holle?
How to update your information.
Scholarly Contributions
230 Scholarly Contributions
Entrectinib for ROS1-positive NSCLC and NTRK-positive solid tumors.
2020
Research Type: Journal Article
Fam-trastuzumab Deruxtecan-nxki for HER2-positive Unresectable or Metastatic Breast Cancer
2020
Research Type: Journal Article
Survey of pharmacists’ knowledge of Connecticut’s medical cannabis program.
2019
Research Type: Journal Article
Duvelisib approved for adults with relapsed or refractory CLL/SLL
2019
Research Type: Journal Article
Demonstrating the value of the oncology pharmacists within the healthcare team.
2019
Research Type: Journal Article
FDA approves esketamine (Spravato™) nasal spray for the treatment of treatment-resistant depression when used in conjunction with an oral antidepressant
2019
Research Type: Journal Article
Applatumide Approved For Non-Metastatic Castrate-Resistant Prostate Cancer
2018
Research Type: Journal Article
Potential role of rituximab in metastatic castrate-resistant prostate cancer.
2018
Research Type: Journal Article
Safe Administration of intra-cerebral spinal fluid (CSF) chemotherapy: time for guidelines. J Oncol Pract
2017
Research Type: Journal Article